FEATURED TOPIC
Why Asset Owners Should Invest in Healthcare Innovation
Why Asset Owners Should Invest in Healthcare Innovation
DISCUSSION HIGHLIGHTS
The pandemic has shed a significant spotlight on the importance of research and innovation in the healthcare sector. However, the rapid production of a coronavirus vaccine is just one example of how powerful it can be. In this session, we looked at the top innovations shaping the healthcare sector today and what opportunities lie ahead for long‑term asset owners.
The pandemic has shed a significant spotlight on the importance of research and innovation in the healthcare sector. However, the rapid production of a coronavirus vaccine is just one example of how powerful it can be. In this session, we looked at the top innovations shaping the healthcare sector today and what opportunities lie ahead for long‑term asset owners.
ADDITIONAL RESOURCES
Healthcare Innovation Strategy
The Great Convergence of Medicine
Investing in Biotech - November 2020
Monday Minute Chats are available to senior decision-makers within Canadian pension funds who are currently subscribed to the CLC Newsletter.
Access to the Monday Minute provides you the link to view at your leisure or share with your team.
Access to the Monday Minute provides you the link to view at your leisure or share with your team.
ROSE NGUYEN
Portfolio Manager, Health Innovation Strategy | Baillie Gifford
Portfolio Manager, Health Innovation Strategy | Baillie Gifford
Rose joined Baillie Gifford in 2013 as an investment analyst. Rose worked on various regional and global strategies before joining the Health Innovation team as a Portfolio Manager.
Having observed the innovations in multiple industries, she believes that the great convergence of different technologies and sciences will ultimately transform life science. Biology can move from alchemy and randomness to become a more predictable, deterministic and repeatable science, that will give rise to a plethora of exciting investment opportunities. She joined the Health Innovation team in September 2018 at the inception of the strategy.
Rose graduated BA (Hons) in Economics and MPhil in Finance and Economics from the University of Cambridge in 2012 and 2013 respectively.
Having observed the innovations in multiple industries, she believes that the great convergence of different technologies and sciences will ultimately transform life science. Biology can move from alchemy and randomness to become a more predictable, deterministic and repeatable science, that will give rise to a plethora of exciting investment opportunities. She joined the Health Innovation team in September 2018 at the inception of the strategy.
Rose graduated BA (Hons) in Economics and MPhil in Finance and Economics from the University of Cambridge in 2012 and 2013 respectively.
Subscribe to our Newsletter
Make sure to never miss another Monday Minute by signing up to the Canadian Leadership Congress Newsletter. You'll be informed of upcoming Chat schedules and exclusive content only available to subscribers.